Alnylam Pharmaceuticals is a leading RNAi therapeutics company based in Cambridge, Massachusetts. They are known for pioneering the innovative approach of silencing disease-causing genes through RNA interference (RNAi). With a strong presence on social media platforms like Facebook, Twitter, and LinkedIn, Alnylam Pharmaceuticals has gained a significant following and is recognized as a fast-growing biopharmaceutical company. Their focus on translating RNAi from a Nobel Prize-winning discovery into a new class of therapeutics sets them apart in the industry.

Alnylam Pharmaceuticals, profile picture · Alnylam Pharmaceuticals. Trial Master File Specialist. January 2018 - Present. Cambridge, Massachusetts. Alnylam ...

Alnylam Pharmaceuticals. @Alnylam. Leader in #RNAiTherapeutics, having pioneered this innovative approach to silencing the genes that cause disease.

Alnylam Pharmaceuticals | 171888 followers on LinkedIn. Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep ...

Alnylam Pharmaceuticals

Find contacts at this company